Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | X011632 | OT / RL |
Nurse called to report AE for a patient after receiving their first dose of MMR II. Patient received her MMR II dose on 03/03/2025, the dose was given subcutaneous on the right thigh. Nurse reports patient experienced a rash on her torso, irritabilit; Nurse called to report AE for a patient after receiving their first dose of MMR II. Patient received her MMR II dose on 03/03/2025, the dose was given subcutaneous on the right thigh. Nurse reports patient experienced a rash on her torso, irritabilit; Nurse called to report AE for a patient after receiving their first dose of MMR II. Patient received her MMR II dose on 03/03/2025, the dose was given subcutaneous on the right thigh. Nurse reports patient experienced a rash on her torso, irritabilit; Nurse called to report AE for a patient after receiving their first dose of MMR II. Patient received her MMR II dose on 03/03/2025, the dose was given subcutaneous on the right thigh. Nurse reports patient experienced a rash on her torso, irritabilit; This spontaneous report was received from a nurse concerning 1-year-old female patient. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 03-MAR-2025, the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) that was diluted with a sterile diluent, subcutaneous Injection (lot #X011632, expiration date: 23-APR-2025), dose number 1, 0.5 mL, administered by Subcutaneous route in Right Thigh as prophylaxis. On 13-MAR-2025, the nurse reported that after receiving their first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), the patient experienced a rash on her torso, irritability and fever of 100.2 F on that day. Then on the following day (14-MAR-2025), the patient still had a fever and rash got worse and was covering her from head to toe. Nurse explained the rash covered her face, chest, torso, hands, all the way down her legs and her feet. Nurse explained the rash was pretty much everywhere and the patient was miserable. Patient was examined by the doctor and no treatment was given. Doctor advised parents of the patient to give acetaminophen (TYLENOL) if needed for fever control and to reach back out if any questions. Consequently, on unspecified date in March 2025 (reported as now) the patient recovered from the events. The causal relationship was not provided.
Sterile diluent
Test Date: 20250313; Test Name: body temperature; Result Unstructured Data: fever 100.2 [degF]